<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05068713</url>
  </required_header>
  <id_info>
    <org_study_id>LIVER-PAM</org_study_id>
    <nct_id>NCT05068713</nct_id>
  </id_info>
  <brief_title>High Versus Low Blood-Pressure Target in the Post Operative Care of Liver Transplantation A Randomized, Controled, Open and Unicentric Trial.</brief_title>
  <acronym>LIVER-PAM</acronym>
  <official_title>High Versus Low Blood-Pressure Target in the Post Operative Care of Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      LIVER PAM&#xD;
&#xD;
      A randomized, controled, open and unicentric trial comparing high (MAP 85-90 mmHg) and low&#xD;
      (65-70 mmHg) target of mean arterial pressure in the first 24 hours after liver&#xD;
      transplantation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 24, 2021</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of Acute Kidney Disfunction</measure>
    <time_frame>7 days</time_frame>
    <description>Incidence of acute kidney Disfunction according to kdigo criteria.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>re-transplant</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical site infection</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver graft primary disfunction</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Substitutive Renal Therapy</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need of Transfusion</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Arrythmia requiring clinical treatment</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lenght of Hospitay Stay</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lenght of ICU Stay</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">174</enrollment>
  <condition>Liver Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>Hihg Target Mean Arterial Pressure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Target of mean arterial pressure of 85-90 mmHg in ther first 24h after liver transplant.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Target Mean Arterial Pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Target of mean arterial pressure of 65-70 mmHg in ther first 24h after liver transplant.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care + High Target of Mean Arterial Pressure</intervention_name>
    <description>Targeting the weaning of vasopressors to a mean arterial pressure of 85-90mmHg in the first 24h after liver trasnplant.</description>
    <arm_group_label>Hihg Target Mean Arterial Pressure</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Usual Care</intervention_name>
    <description>Targeting the weaning of vasopressors to a mean arterial pressure of 65-70mmHg in the first 24h after liver trasnplant.</description>
    <arm_group_label>Low Target Mean Arterial Pressure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Older than 18 y&#xD;
&#xD;
          -  Admitted in the ICU for a post operative care after liver transplant&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Consent refusal&#xD;
&#xD;
          -  Liver transplant due to acute liver failure&#xD;
&#xD;
          -  Renal transplant ( Previous or concomitant)&#xD;
&#xD;
          -  Refusal from the healthcare provider responsible for the patient&#xD;
&#xD;
          -  Renal substitution therapy in the prior 15 days&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Re-Transplant (Liver transplant in the previous 6 month)&#xD;
&#xD;
          -  Hepatorenal syndrome current treatment (Use of terlipressin + Albumin)&#xD;
&#xD;
          -  Refractory and persistent shock during or after transplant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Das Clínicas Da Faculdade de Medicina Da Universidade de São Paulo</name>
      <address>
        <city>São Paulo</city>
        <state>SAO Paulo</state>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>RODOLPHO PEDRO, MD</last_name>
      <phone>+5511966470708</phone>
      <email>rodolphopedro@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 24, 2021</study_first_submitted>
  <study_first_submitted_qc>October 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 6, 2021</study_first_posted>
  <last_update_submitted>October 5, 2021</last_update_submitted>
  <last_update_submitted_qc>October 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Rodolpho Augusto de Moura Pedro</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

